C3 and breast carcinoma: An analysis [79] of expression patterns for acute phase proteins in breast, colorectal, and lung cancer indicate that the most accurate candidate biomarker for breast cancer in their panel was Complement 3 (C3) as used in a univariate logisitic regression model (AUC = 0.89 and 73% correct classification performance in leave one out cross-validation).